PeptidePedia The community reference

Talk:Grey market

Discussion page·2 threads·no archives

This article is within the scope of the regulation working group.

This is the discussion page for the article Grey market. It is for improving the article: sources, wording, structure, scope and titles. It is not a general discussion forum about the subject, and it is not a place to ask for advice — see Project:Medical disclaimer.

Is the term useful here at all?Resolved

Much of this market has no authorised channel, so the term does less work than people think. The article says so, which is more honest than pretending the category is central. — GreyMarketGreer (talk) 09:40, 30 March 2026 (UTC)

Defining a term readers will encounter is a legitimate reason for an article to exist even where the category is marginal. ✓ Done — ScopeSeverin (talk) 13:15, 30 March 2026 (UTC)

Resolved. This thread is closed. Reopening it is fine if new sources appear; please add a new subsection rather than editing the closed discussion.

Unknown is not badDone

"Handling history is unknown, which is not the same as bad" is the correction most needed here. — BalanceBirdie (talk) 10:05, 4 June 2026 (UTC)

Same asymmetry as the custody article. Unknown provenance limits what a result can establish in either direction. ✓ Done — ChainCustodyChad (talk) 13:40, 4 June 2026 (UTC)

Done. This thread is closed. Reopening it is fine if new sources appear; please add a new subsection rather than editing the closed discussion.
This page was last edited on 4 June 2026, by ChainCustodyChad. Text is available under the PeptidePedia Wiki Content Licence (PPCL-BY-SA 4.0).